SVT-6A4710
/ Servatus
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 16, 2025
Testing safety and efficacy of a live bacterial therapy for the treatment of active Rheumatoid Arthritis.
(ANZCTR)
- P1/2 | N=45 | Active, not recruiting | Sponsor: Servatus Ltd | Recruiting ➔ Active, not recruiting | N=80 ➔ 45
Enrollment change • Enrollment closed • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
August 30, 2024
Testing safety and efficacy of a live bacterial therapy for the treatment of active Rheumatoid Arthritis.
(ANZCTR)
- P1/2 | N=80 | Recruiting | Sponsor: Servatus Ltd | N=45 ➔ 80
Enrollment change • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology • CRP
1 to 2
Of
2
Go to page
1